Paritaprevir Catalog No.:M18869-C ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15

ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15

4SC-202 was dosed to A549 NSCLC xenograft model and RKO27 colon carcinoma xenografts model orally at 120 mg/Kg once per day

Smiles: CC1=CC=CN2C(=O)C(/C=C(\C#N)/C3=NC4=CC=CC=C4S3)=C(N=C21)OC1C=CC(F)=CC=1

5(4):eaav4340

Smiles: CN1C=C(C2=C1N=CN=C2N)C1=CC=C2C(CCN2C(=O)CC2=CC=CC(C)=N2)=C1F

Paritaprevir Catalog No.:M18869-C ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15Paritaprevir (ABT 450) is a potent non structural protein 3 4A (NS3 4A) protease inhibitor with EC50s of 1 and 0. 21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS CoV 3CLpro inhibitor with an IC50 of 1. 31 M. Product information CAS Number: 1216941 48 8 Molecular Weight: 765. 88 Formula: C40H43N7O7S Chemical Name: (1S,4R,6S,14S,18R) N (cyclopropanesulfonyl) 14 (5 methylpyrazine 2 amido) 2,15 dioxo 18 (phenanthridin 6 yloxy) 3,16